10-QPeriod: Q2 FY2024

AXON ENTERPRISE, INC. Quarterly Report for Q2 Ended Jun 30, 2024

Filed August 7, 2024For Securities:AXON

Summary

Axon Enterprise, Inc. (AXON) reported strong revenue growth in its Form 10-Q for the period ending June 30, 2024. Total net sales increased by 34.6% year-over-year to $504.1 million for the quarter, and by 34.4% to $964.8 million for the six-month period. This growth was driven by both the TASER segment (up 27.6% quarterly) and the Software and Sensors segment (up 39.5% quarterly), with notable increases in TASER devices, cartridges, and Axon Body Cameras and Accessories. The company also saw a significant rise in its recurring revenue from cloud services. Despite robust top-line growth, operating income decreased year-over-year for both the quarter ($32.9 million vs. $40.3 million) and the six-month period ($49.2 million vs. $56.9 million). This was primarily attributed to increased operating expenses, particularly higher stock-based compensation and R&D investments, as well as amortization of acquired intangibles. The company's gross margin percentage also saw a slight decrease, impacted by these factors, although adjusted gross margin (excluding stock-based compensation and amortization) showed improvement, particularly in the Software and Sensors segment. Significant strategic investments and business acquisitions, including the acquisition of Fusus and the pending acquisition of Dedrone, are noted as key drivers of future growth and integration efforts.

Financial Statements
Beta

Key Highlights

  • 1Total net sales for the quarter ended June 30, 2024, increased 34.6% year-over-year to $504.1 million.
  • 2The Software and Sensors segment showed strong growth, with net sales up 39.5% year-over-year to $307.1 million for the quarter.
  • 3The TASER segment also contributed to growth, with net sales up 27.6% year-over-year to $197.0 million for the quarter.
  • 4Gross margin percentage decreased slightly year-over-year to 60.3% for the quarter, primarily due to increased stock-based compensation and amortization expenses.
  • 5Operating expenses increased significantly, driven by higher headcount, sales and marketing, and R&D investments.
  • 6The company completed the acquisition of the remaining interest in Fusus, LLC for approximately $241.3 million and announced a definitive agreement to acquire Dedrone Holdings, Inc. for approximately $400.0 million.
  • 7Remaining performance obligations stood at approximately $7.4 billion as of June 30, 2024, indicating substantial future contracted revenue.

Frequently Asked Questions

Revenue growth was primarily driven by strong performance in both the TASER segment, particularly in TASER devices and cartridges, and the Software and Sensors segment, with significant contributions from Axon Body Cameras and Accessories and Axon Evidence and Cloud Services. The ongoing adoption of cloud-based solutions and increased unit sales of key hardware products were major contributors.

Operating income decreased due to a significant increase in operating expenses. This was primarily driven by higher stock-based compensation expenses related to new equity plans and increased headcount, along with substantial investments in research and development and amortization of acquired intangible assets stemming from recent acquisitions.

The $7.4 billion in remaining performance obligations represents the total value of contracted future revenues that Axon expects to recognize over the coming years. This figure indicates a strong, contracted backlog and provides visibility into future revenue streams, though it is subject to risks like delayed deployments and contract cancellation clauses.

The acquisition of Fusus and the planned acquisition of Dedrone are strategic moves to expand Axon's offerings in real-time crime center technology and air space security, respectively. These acquisitions are expected to drive future growth by enhancing situational awareness, investigative capabilities, and drone defense solutions, though they also contribute to increased operating expenses and amortization costs in the near term.